In the group of patients with clear cell carcinoma, there was no significant difference in CSS in patients with serum adiponectin ≥ 8.8 μg/ml and patients with serum adiponectin < 8.8 μg/ml (Fig 3A and 3B, S1 Table). Here, ADIPOQ is linked to clear cell adenocarcinoma.